A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer

Clinical Trial of Evaluating TQB3912 Tablets Combined With Fulvestrant Injection±TQB3616 Capsules for Locally Advanced or Metastatic Hormone Receptor(HR)-Positive and Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer

NCT06851442 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

A Clinical Study of TQB2102 Versus Docetaxel Plus Trastuzumab and Pertuzumab in the Treatment of HER2 Positive Recurrent or Metastatic Breast Cancer

NCT07003074 ·Status: RECRUITING ·Phase: PHASE3

Clinical Trial of TQB2102 for Injection Versus Trastuzumab Emtansine for Injection in HER2-positive Advanced Breast Cancer

NCT07008976 ·Status: RECRUITING ·Phase: PHASE3

TQB2930 Injection for the Treatment of HER2-positive Advanced Breast Cancer

NCT07047365 ·Status: RECRUITING ·Phase: PHASE3

A Clinical Trial Evaluating TQB2102 for Injection in Combination With Behmosubaisumab/Payamprolizumab With or Without Chemotherapy in Unresectable Locally Advanced, Recurrent, or Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Gastroesophageal Adenocarcinoma

NCT06767800 ·Status: RECRUITING ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of the Combination of TQ-B211 Plus Docetaxel in Patients With HER2-positive MBC.

NCT04385563 ·Status: UNKNOWN ·Phase: PHASE3

A Phase Ib/Ⅱ Study of NTQ1062 in Combination With Fulvestrant in Patients With Advanced HR Positive /HER-2 Negative Breast Cancer

NCT06172322 ·Status: RECRUITING ·Phase: PHASE1

Trastuzumab Rezetecan Combined With Pertuzumab and Iparomlimab and Tuvonralimab for Biliary Tract Cancer

NCT07129018 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Phase II Clinical Study of SHR-A1811 in Patients With HER2 Expression / Amplification of Locally Advanced Unresectable or Recurrent Metastatic Biliary Tract Cancer

NCT06413745 ·Status: RECRUITING ·Phase: PHASE2

A Clinical Study to Evaluate the Efficacy and Safety of TQB3702 Tablets Combined With Immunochemotherapy for the Treatment of B-cell Lymphoma

NCT06566586 ·Status: RECRUITING ·Phase: PHASE2

A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

NCT05150691 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Durvalumab Combined With S-1 as Adjuvant Therapy of Resectable BTC

NCT06490107 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Clinical Study to Evaluate the Efficacy and Safety of TQB2440 Injection/Perjeta® Combined With Trastuzumab and Docetaxel in the Treatment of Patients With Early or Locally Advanced Breast Cancer.

NCT05985187 ·Status: UNKNOWN ·Phase: PHASE3

A Phase II Clinical Study of HRS-7058 in Combination With Antitumor Drugs in Patients With Advanced Malignant Tumour

NCT06915142 ·Status: RECRUITING ·Phase: PHASE2

A Multicenter, Double-blind, Randomized, Parallel-group, Phase III Study of the Efficacy and Safety of QL1701 Plus Docetaxel Versus Herceptin® Plus Docetaxel as First Line Therapy in Patients With HER2-positive Metastatic Breast Cancer

NCT05629949 ·Status: COMPLETED ·Phase: PHASE3

Phase 1, Multiple Ascending Dose Study of Anti-HER2 FCAB FS102 in HER2 Positive Solid Tumors (Anti HER2 Fcab)

NCT02286219 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Study of SHR-A1811 in the Treatment of HER2-positive Locally Advanced or Metastatic Biliary Tract Cancer

NCT06778031 ·Status: RECRUITING ·Phase: PHASE2

HB1801 Combined Treatment of HER2-positive Breast Cancer

NCT07116824 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Phase 2 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of YL202 in Patients With BC

NCT06439771 ·Status: RECRUITING ·Phase: PHASE2

BGB-43395 Alone or as Part of Combination Therapies in Chinese Participants With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

NCT06253195 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Efficacy and Safety of Trastuzumab Emtansine in Chinese Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced or Metastatic Breast Cancer

NCT03084939 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of TQB3616 Capsules in a Phase II Clinical Trial for Recurrent/Metastatic Breast Cancer

NCT06702618 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Safety of GQ1001 in Adult Patients With HER2-Positive Advanced Solid Tumors

NCT04450732 ·Status: RECRUITING ·Phase: PHASE1

Phase 1b/2 Study to Evaluate ABT-101 in Solid Tumor and NSCLC Patients

NCT05532696 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Study of MRG002 in Treatment of Advanced HER-2 Positive Breast Cancer Patients

NCT05263869 ·Status: UNKNOWN ·Phase: PHASE2